AV-1959D

· Institute for Molecular Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AV-1959D, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of AV-1959D, an Amyloid Beta Vaccine [Phase 1]